Signet Therapeutics Company

Signet Therapeutics is a biopharmaceutical startup focusing on developing innovative targeted cancer drugs using novel disease models.

Last Funding Type: Seed
Headquarters: Newton, Massachusetts, United States
Total Funding: 20000000
Funding Status: Seed
Industry: Early and Preclinical Drug Development
Last Funding Date: 2021-10-29
Founded Date: 2020-01-01
Investors Number: 5